Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$21.55
-0.62-2.80%
al cierre: -
$21.62
0.070.32%
After hour: 4:19 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Acadia Healthcare Co Inc ha un obiettivo di prezzo di consenso pari a $58.91, stabilito in base alle ultime valutazioni degli analisti di 17. Le ultime 3 valutazioni degli analisti sono state rilasciate da Raymond James, Mizuho y RBC Capital il agosto 14, 2025, agosto 14, 2025 y agosto 13, 2025. Con un obiettivo di prezzo medio di $25.33 tra le Raymond James, Mizuho y RBC Capital, c'è un implicito 17.18% upside per Acadia Healthcare Co Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Raymond James
Mizuho
RBC Capital
UBS
Guggenheim
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Acadia Healthcare Co
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/14/2025 | 20.26% | Raymond James | $40 → $26 | Downgrade | Strong Buy → Outperform | |||
08/14/2025 | 1.76% | Mizuho | $32 → $22 | Maintains | Neutral | |||
08/13/2025 | 29.51% | RBC Capital | $43 → $28 | Maintains | Outperform | |||
08/07/2025 | 43.39% | UBS | $45 → $31 | Maintains | Buy | |||
08/07/2025 | 34.14% | Guggenheim | $36 → $29 | Maintains | Buy | |||
08/07/2025 | -7.49% | Barclays | $28 → $20 | Maintains | Equal-Weight | |||
05/14/2025 | 48.01% | Mizuho | $37 → $32 | Maintains | Neutral | |||
05/14/2025 | 29.51% | Barclays | $35 → $28 | Maintains | Equal-Weight | |||
05/14/2025 | 154.39% | Keybanc | $65 → $55 | Maintains | Overweight | |||
04/09/2025 | 66.51% | Guggenheim | → $36 | Initiates | → Buy | |||
03/25/2025 | 71.14% | Mizuho | $48 → $37 | Maintains | Neutral | |||
03/03/2025 | 98.89% | RBC Capital | $64 → $43 | Maintains | Outperform | |||
03/03/2025 | 200.65% | Keybanc | $70 → $65 | Maintains | Overweight | |||
02/28/2025 | 61.89% | Barclays | $43 → $35 | Downgrade | Overweight → Equal-Weight | |||
02/28/2025 | 105.83% | B of A Securities | $50 → $44.5 | Maintains | Buy | |||
01/10/2025 | 196.02% | RBC Capital | $64 → $64 | Reiterates | Outperform → Outperform | |||
01/07/2025 | 205.27% | TD Cowen | $70 → $66 | Maintains | Buy | |||
01/07/2025 | 223.77% | Keybanc | → $70 | Upgrade | Sector Weight → Overweight | |||
12/12/2024 | 246.9% | Deutsche Bank | $45 → $75 | Upgrade | Hold → Buy | |||
12/10/2024 | 140.52% | Cantor Fitzgerald | $52 → $52 | Reiterates | Neutral → Neutral | |||
11/22/2024 | 98.89% | Barclays | $76 → $43 | Maintains | Overweight | |||
11/18/2024 | 196.02% | RBC Capital | $94 → $64 | Maintains | Outperform | |||
10/11/2024 | — | Keybanc | — | Initiates | → Sector Weight | |||
10/04/2024 | 316.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Neutral → Neutral | |||
10/01/2024 | 316.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Neutral → Neutral | |||
09/30/2024 | 251.53% | Barclays | $83 → $76 | Maintains | Overweight | |||
09/20/2024 | 334.78% | RBC Capital | $94 → $94 | Reiterates | Outperform → Outperform | |||
08/20/2024 | 316.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Neutral → Neutral | |||
08/19/2024 | 316.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Neutral → Neutral | |||
08/02/2024 | 246.9% | Deutsche Bank | $70 → $75 | Maintains | Hold | |||
08/02/2024 | 316.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Neutral → Neutral | |||
08/01/2024 | 316.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Neutral → Neutral | |||
08/01/2024 | 283.9% | Barclays | $89 → $83 | Maintains | Overweight | |||
07/10/2024 | 316.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Neutral → Neutral | |||
07/09/2024 | 316.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Neutral → Neutral | |||
07/02/2024 | 316.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Neutral → Neutral | |||
05/22/2024 | 334.78% | RBC Capital | $94 → $94 | Reiterates | Outperform → Outperform | |||
05/17/2024 | 320.91% | TD Cowen | $101 → $91 | Maintains | Buy | |||
05/15/2024 | 311.66% | Barclays | $91 → $89 | Maintains | Overweight | |||
05/03/2024 | 223.77% | Mizuho | $84 → $70 | Maintains | Neutral | |||
05/02/2024 | 316.28% | B of A Securities | $105 → $90 | Maintains | Buy | |||
05/02/2024 | 320.91% | Barclays | $100 → $91 | Maintains | Overweight | |||
04/25/2024 | 223.77% | Deutsche Bank | → $70 | Upgrade | Sell → Hold | |||
03/06/2024 | 288.53% | Mizuho | $77 → $84 | Maintains | Neutral | |||
03/06/2024 | 362.53% | Barclays | → $100 | Initiates | → Overweight | |||
03/05/2024 | 316.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Neutral → Neutral | |||
03/04/2024 | 334.78% | RBC Capital | $94 → $94 | Reiterates | Outperform → Outperform | |||
03/01/2024 | 367.16% | TD Cowen | $86 → $101 | Maintains | Outperform | |||
02/28/2024 | 371.79% | UBS | $88 → $102 | Maintains | Buy | |||
01/05/2024 | 325.53% | Stephens & Co. | → $92 | Upgrade | Equal-Weight → Overweight | |||
11/07/2023 | 334.78% | RBC Capital | $99 → $94 | Maintains | Outperform | |||
09/14/2023 | 293.15% | Cantor Fitzgerald | $83 → $85 | Maintains | Neutral | |||
07/31/2023 | 357.91% | RBC Capital | $93 → $99 | Maintains | Outperform | |||
07/31/2023 | 339.41% | Credit Suisse | → $95 | Reiterates | Outperform → Outperform | |||
07/28/2023 | 307.03% | UBS | $92 → $88 | Maintains | Buy | |||
07/12/2023 | 283.9% | Stephens & Co. | → $83 | Reiterates | Equal-Weight → Equal-Weight | |||
06/02/2023 | 283.9% | Stephens & Co. | → $83 | Reiterates | Equal-Weight → Equal-Weight | |||
05/04/2023 | 339.41% | Credit Suisse | $93 → $95 | Maintains | Outperform | |||
04/28/2023 | 339.41% | Credit Suisse | $93 → $95 | Maintains | Outperform | |||
04/27/2023 | 307.03% | Stephens & Co. | → $88 | Reiterates | → Equal-Weight | |||
04/24/2023 | 325.53% | UBS | $96 → $92 | Maintains | Buy | |||
04/20/2023 | 191.4% | Deutsche Bank | $75 → $63 | Downgrade | Hold → Sell | |||
03/06/2023 | 246.9% | Deutsche Bank | $82 → $75 | Maintains | Hold | |||
03/06/2023 | 270.03% | Mizuho | $87 → $80 | Maintains | Neutral | |||
03/01/2023 | 307.03% | Stephens & Co. | $92 → $88 | Maintains | Equal-Weight | |||
02/28/2023 | 325.53% | Stephens & Co. | → $92 | Reiterates | → Equal-Weight | |||
12/12/2022 | 330.16% | RBC Capital | $94 → $93 | Maintains | Outperform | |||
12/12/2022 | 339.41% | Loop Capital | → $95 | Upgrade | Hold → Buy | |||
12/08/2022 | 302.41% | Mizuho | $80 → $87 | Maintains | Neutral | |||
12/08/2022 | 307.03% | Stephens & Co. | $86 → $88 | Maintains | Equal-Weight | |||
11/02/2022 | 297.78% | Stephens & Co. | $85 → $86 | Maintains | Equal-Weight | |||
11/02/2022 | 270.03% | Mizuho | $78 → $80 | Maintains | Neutral |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Acadia Healthcare Co (ACHC)?
El último precio objetivo de Acadia Healthcare Co (NASDAQ:ACHC) fue comunicado por Raymond James el agosto 14, 2025. La firma de analistas fijó un precio objetivo para $26.00 que espera ACHC a rise dentro de 12 meses (un posible 20.26% upside). 27 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Acadia Healthcare Co (ACHC)?
La última calificación de analistas para Acadia Healthcare Co (NASDAQ:ACHC) fue proporcionada por Raymond James, y Acadia Healthcare Co rebajado su outperform calificación.
¿Cuándo se produjo la última revisión al alza de Acadia Healthcare Co (ACHC)?
La última revisión al alza de Acadia Healthcare Co Inc se produjo en enero 7, 2025, cuando Keybanc elevó su precio objetivo a $70. Keybanc anteriormente tenía a sector weight para Acadia Healthcare Co Inc.
¿Cuándo fue la última revisión a la baja de Acadia Healthcare Co (ACHC)?
La última revisión a la baja de Acadia Healthcare Co Inc se produjo en agosto 14, 2025, cuando Raymond James cambió su precio objetivo de $40 a $26 para Acadia Healthcare Co Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Acadia Healthcare Co (ACHC)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Acadia Healthcare Co, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Acadia Healthcare Co se registró el agosto 14, 2025, por lo que la próxima calificación estará disponible en torno al agosto 14, 2026.
¿Es correcta la calificación de los analistas sobre Acadia Healthcare Co (ACHC)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Acadia Healthcare Co (ACHC) fue un rebajado con un precio objetivo de $40.00 a $26.00. El precio actual al que cotiza Acadia Healthcare Co (ACHC) es de $21.62, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.